AI Portfolio Summary
In 2024 Q4, Boxer Capital, LLC maintained a portfolio of 68 distinct positions.
Total Positions
68
Quarter
2024 Q4
Top Holding
RVMD (9.5%)
Top 10 Concentration
54.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 68
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
Revolution Medi...
|
Healthcare | 9.52% | 9.52% |
#1
Prev: #1
|
6.8 | no change | no change |
P
S
|
4,279,464 | $194,073,692 | 2020 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
TYRA
Tyra Bioscience...
|
Healthcare | 7.44% | 7.44% |
#2
Prev: #2
|
5.5 | no change | no change |
P
S
|
6,448,359 | $151,600,920 | 2021 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
NUVL
Nuvalent Inc
|
Healthcare | 5.62% | 5.62% |
#3
Prev: #3
|
4.2 | no change | no change |
P
S
|
1,120,192 | $114,595,642 | 2021 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ONC
BeiGene Ltd
|
Healthcare | 5.51% | 5.51% |
#4
Prev: #4
|
3.7 | no change | no change |
P
S
|
500,000 | $112,255,000 | 2016 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
CYTK
Cytokinetics In...
|
Healthcare | 5.44% | 5.44% |
#5
Prev: #5
|
3.7 | no change | no change |
P
S
|
2,100,000 | $110,880,000 | 2020 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
SWTX
Springworks The...
|
Unknown | 5.38% | 5.38% |
#6
Prev: #6
|
3.2 | no change | no change |
P
S
|
3,421,541 | $109,626,174 | 2019 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
MRUS
Merus N V
|
Healthcare | 4.66% | 4.66% |
#7
Prev: #7
|
2.9 | no change | no change |
P
S
|
1,900,000 | $94,924,000 | 2020 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
SRPT
Sarepta Therape...
|
Healthcare | 3.98% | 3.98% |
#8
Prev: #8
|
2.6 | no change | no change |
P
S
|
650,000 | $81,178,500 | 2018 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
RNA
Avidity Bioscie...
|
Healthcare | 3.89% | 3.89% |
#9
Prev: #9
|
2.6 | no change | no change |
P
S
|
1,727,388 | $79,338,931 | 2020 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
IDYA
Ideaya Bioscien...
|
Healthcare | 3.42% | 3.42% |
#10
Prev: #10
|
2.4 | no change | no change |
P
S
|
2,202,812 | $69,785,084 | 2019 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
TNGX
Tango Therapeut...
|
Healthcare | 3.10% | 3.10% |
#11
Prev: #11
|
2.2 | no change | no change |
P
S
|
8,198,642 | $63,129,543 | 2021 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ARGX
Argenx SE
|
Healthcare | 2.66% | 2.66% |
#12
Prev: #12
|
2.1 | no change | no change |
P
S
|
100,000 | $54,208,000 | 2019 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
APLS
Apellis Pharmac...
|
Healthcare | 2.44% | 2.44% |
#13
Prev: #13
|
2.0 | no change | no change |
P
S
|
1,726,000 | $49,777,840 | 2019 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
AKRO
Akero Therapeut...
|
Healthcare | 2.36% | 2.36% |
#14
Prev: #14
|
1.9 | no change | no change |
P
S
|
1,676,733 | $48,105,470 | 2019 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ANAB
AnaptysBio Inc
|
Healthcare | 2.14% | 2.14% |
#15
Prev: #15
|
1.9 | no change | no change |
P
S
|
1,300,000 | $43,550,000 | 2017 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
AXSM
Axsome Therapeu...
|
Healthcare | 1.76% | 1.76% |
#16
Prev: #16
|
1.7 | no change | no change |
P
S
|
400,000 | $35,948,000 | 2020 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ITOS
iTeos Therapeut...
|
Unknown | 1.48% | 1.48% |
#17
Prev: #17
|
1.6 | no change | no change |
P
S
|
2,946,915 | $30,088,002 | 2020 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
LEGN
Legend Biotech ...
|
Healthcare | 1.43% | 1.43% |
#18
Prev: #18
|
1.6 | no change | no change |
P
S
|
600,000 | $29,238,000 | 2023 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
GERN
Geron Corp
|
Healthcare | 1.34% | 1.34% |
#19
Prev: #19
|
1.5 | no change | no change |
P
S
|
6,000,000 | $27,240,000 | 2022 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
THRD
Third Harmonic ...
|
Unknown | 1.33% | 1.33% |
#20
Prev: #20
|
1.5 | no change | no change |
P
S
|
2,000,000 | $27,100,000 | 2022 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
RCKT
Rocket Pharmace...
|
Healthcare | 1.33% | 1.33% |
#21
Prev: #21
|
1.5 | no change | no change |
P
S
|
1,466,051 | $27,077,962 | 2018 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
RCUS
Arcus Bioscienc...
|
Healthcare | 1.20% | 1.20% |
#22
Prev: #22
|
1.5 | no change | no change |
P
S
|
1,602,200 | $24,497,638 | 2019 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
TIL
Instil Bio Inc
|
Healthcare | 1.17% | 1.17% |
#23
Prev: #23
|
1.5 | no change | no change |
P
S
|
355,500 | $23,932,260 | 2024 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
XENE
Xenon Pharmaceu...
|
Healthcare | 1.16% | 1.16% |
#24
Prev: #24
|
1.5 | no change | no change |
P
S
|
600,000 | $23,622,000 | 2018 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
IMVT
Immunovant Inc
|
Healthcare | 1.15% | 1.15% |
#25
Prev: #25
|
1.5 | no change | no change |
P
S
|
825,000 | $23,520,750 | 2021 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
KYMR
Kymera Therapeu...
|
Healthcare | 1.05% | 1.05% |
#26
Prev: #26
|
1.4 | no change | no change |
P
S
|
450,000 | $21,298,500 | 2024 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
SYRE
Spyre Therapeut...
|
Healthcare | 1.01% | 1.01% |
#27
Prev: #27
|
1.4 | no change | no change |
P
S
|
696,480 | $20,483,477 | 2023 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
KURA
Kura Oncology I...
|
Healthcare | 0.96% | 0.96% |
#28
Prev: #28
|
1.4 | no change | no change |
P
S
|
1,000,000 | $19,540,000 | 2015 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
KALV
Kalvista Pharma...
|
Healthcare | 0.90% | 0.90% |
#29
Prev: #29
|
1.4 | no change | no change |
P
S
|
1,590,000 | $18,412,200 | 2018 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
NKTX
Nkarta Inc
|
Healthcare | 0.89% | 0.89% |
#30
Prev: #30
|
1.4 | no change | no change |
P
S
|
4,029,606 | $18,213,819 | 2023 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ORIC
Oric Pharmaceut...
|
Healthcare | 0.87% | 0.87% |
#31
Prev: #31
|
1.3 | no change | no change |
P
S
|
1,732,571 | $17,758,853 | 2020 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
GPCR
Structure Thera...
|
Healthcare | 0.86% | 0.86% |
#32
Prev: #32
|
1.3 | no change | no change |
P
S
|
400,000 | $17,556,000 | 2023 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
FATE
Fate Therapeuti...
|
Healthcare | 0.85% | 0.85% |
#33
Prev: #33
|
1.3 | no change | no change |
P
S
|
4,960,910 | $17,363,185 | 2021 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ELVN
Enliven Therape...
|
Healthcare | 0.84% | 0.84% |
#34
Prev: #34
|
1.3 | no change | no change |
P
S
|
671,358 | $17,146,483 | 2023 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
REPL
Replimune Group...
|
Healthcare | 0.83% | 0.83% |
#35
Prev: #35
|
1.3 | no change | no change |
P
S
|
1,536,341 | $16,838,297 | 2024 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
DAWN
Day One Biophar...
|
Healthcare | 0.81% | 0.81% |
#36
Prev: #36
|
1.3 | no change | no change |
P
S
|
1,189,943 | $16,575,906 | 2021 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
CGEM
Cullinan Therap...
|
Healthcare | 0.75% | 0.75% |
#37
Prev: #37
|
1.3 | no change | no change |
P
S
|
907,895 | $15,198,162 | 2021 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ARVN
Arvinas Inc
|
Healthcare | 0.74% | 0.74% |
#38
Prev: #38
|
1.3 | no change | no change |
P
S
|
608,614 | $14,990,163 | 2019 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
CLYM
Eliem Therapeut...
|
Healthcare | 0.65% | 0.65% |
#39
Prev: #39
|
1.3 | no change | no change |
P
S
|
2,603,190 | $13,250,237 | 2024 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
RLAY
Relay Therapeut...
|
Healthcare | 0.63% | 0.63% |
#40
Prev: #40
|
1.3 | no change | no change |
P
S
|
1,819,132 | $12,879,455 | 2020 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
NRIX
Nurix Therapeut...
|
Healthcare | 0.62% | 0.62% |
#41
Prev: #41
|
1.2 | no change | no change |
P
S
|
563,067 | $12,652,115 | 2020 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
PRTA
Prothena Corp P...
|
Healthcare | 0.57% | 0.57% |
#42
Prev: #42
|
1.2 | no change | no change |
P
S
|
690,000 | $11,543,700 | 2019 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
QURE
Uniqure NV
|
Healthcare | 0.54% | 0.54% |
#43
Prev: #43
|
1.2 | no change | no change |
P
S
|
2,225,000 | $10,969,250 | 2018 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
APGE
Apogee Therapeu...
|
Healthcare | 0.52% | 0.52% |
#44
Prev: #44
|
1.2 | no change | no change |
P
S
|
179,000 | $10,514,460 | 2024 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
OLMA
Olema Pharmaceu...
|
Healthcare | 0.38% | 0.38% |
#45
Prev: #45
|
1.2 | no change | no change |
P
S
|
650,000 | $7,761,000 | 2024 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
IOVA
Iovance Biother...
|
Healthcare | 0.35% | 0.35% |
#46
Prev: #46
|
1.1 | no change | no change |
P
S
|
750,000 | $7,042,500 | 2020 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
IPSC
Century Therape...
|
Healthcare | 0.33% | 0.33% |
#47
Prev: #47
|
1.1 | no change | no change |
P
S
|
3,900,000 | $6,669,000 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
JSPR
Jasper Therapeu...
|
Healthcare | 0.32% | 0.32% |
#48
Prev: #48
|
1.1 | no change | no change |
P
S
|
350,000 | $6,583,500 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
SANA
Sana Biotechnol...
|
Healthcare | 0.32% | 0.32% |
#49
Prev: #49
|
1.1 | no change | no change |
P
S
|
1,545,000 | $6,427,200 | 2024 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
TERN
Terns Pharmaceu...
|
Healthcare | 0.31% | 0.31% |
#50
Prev: #50
|
1.1 | no change | no change |
P
S
|
752,000 | $6,271,680 | 2024 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) |
Showing 1-50 of 68 holdings